Cargando…
Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial
BACKGROUND: Atrial fibrillation (AF) is common in older people with frailty and is associated with an increased risk of stroke and systemic embolism. Whilst oral anticoagulation is associated with a reduction in this risk, there is a lack of data on the safety and efficacy of direct oral anticoagula...
Autores principales: | Wilkinson, Chris, Wu, Jianhua, Searle, Samuel D., Todd, Oliver, Hall, Marlous, Kunadian, Vijay, Clegg, Andrew, Rockwood, Kenneth, Gale, Chris P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758931/ https://www.ncbi.nlm.nih.gov/pubmed/33357217 http://dx.doi.org/10.1186/s12916-020-01870-w |
Ejemplares similares
-
Atrial fibrillation and oral anticoagulation in older people with frailty: a nationwide primary care electronic health records cohort study
por: Wilkinson, Chris, et al.
Publicado: (2020) -
Management of atrial fibrillation for older people with frailty: a systematic review and meta-analysis
por: Wilkinson, Chris, et al.
Publicado: (2019) -
Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial
por: Kato, Eri Toda, et al.
Publicado: (2016) -
Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF‐TIMI 48 Trial
por: Eisen, Alon, et al.
Publicado: (2016) -
Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial
por: Fanola, Christina L., et al.
Publicado: (2018)